Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Article Curations by Other Authors:

Editor-in-Chief’s Commissions and Investigator-initiated Articles on

MedTech and Cardiovascular Medical Devices

Published by LPBI Group’s Team Members

On 8/13/2018, Curations by LPBI TEAM members N = 37

 

Patients expression of individual experience with Open Heart Surgery

https://pharmaceuticalintelligence.com/biomed-e-books/series-e-titles-in-the-strategic-plan-for-2014-1015/2014-the-patients-voice-personal-experience-with-invasive-medical-procedures/

 

The Voice of Open Heart Surgery Survivors

• A Patient’s Perspective: On Open Heart Surgery from Diagnosis and Intervention to Recovery – A New Day, a New Lease and Unfolding Questions!
• Triple-bypass operation at age 69 – Ralph’s Story: An Entertainer at Heart
• A Fantastic Vessel-Clearing Innovation on The vessel-clearing device, U.S. Patent No. 8,663,209

 

These three articles are in Chapter 8: Cardiac Surgery, in

The VOICES of Patients, Hospitals CEOs, Health Care Providers, Caregivers and Families: Personal Experience with Critical Care and Invasive Medical Procedures, 2017. On Amazon.com since 10/16/2017

https://www.amazon.com/dp/B076HGB6MZ

 

Article Curations by Other Authors:

Commissions and Investigator-initiated Articles on

MedTech and Cardiovascular Medical Devices Published by

LPBI Group’s Team Members

 

43o    Commentaries on each Volume’s Contribution to Medical Education by L.H. Bernstein, MD, FCAP and Aviva Lev-Ari, PhD, RN – BioMedical e-Books e-Series: Multiple Volumes in Five e-Series

Author: Larry H. Bernstein, MD, FCAP

https://pharmaceuticalintelligence.com/biomed-e-books/commentaries-on-each-volumes-contribution-to-medical-education-by-l-h-bernstein-md-fcap-and-aviva-lev-ari-phd-rn-biomedical-e-books-e-series-multiple-volumes-in-five-e-series/

 

42o    Coronary Artery Interventions: balloon, stent, drug-eluting and antiplatelet demand

Curator: Justin D Pearlman, MD, PhD, FACC

https://pharmaceuticalintelligence.com/2018/08/05/coronary-artery-interventions-balloon-stent-drug-eluting-stent-and-antiplatelet-demand/

 

41o    3D revolution and tissue repair

Curator: Larry H. Bernstein, MD, FCAP

https://pharmaceuticalintelligence.com/2016/04/11/3d-revolution-and-tissue-repair/

 

40o    Kurzweill Reports in Medical Science I

Curator: Larry H. Bernstein, MD, FCAP

https://pharmaceuticalintelligence.com/2015/11/21/kurzweill-reports-in-medical-science-i/

 

39o    Control Heartbeats using Light

Curator: Larry H. Bernstein, MD, FCAP

https://pharmaceuticalintelligence.com/2015/10/25/control-heartbeats-using-light/

 

38o    Outstanding Achievement in Pathology

Curator: Larry H Bernstein, MD, FCAP

https://pharmaceuticalintelligence.com/2015/09/26/outstanding-achievement-in-pathology/

 

37o    Outstanding Achievement in Anesthesiology

Curator: Larry H Bernstein, MD, FCAP

https://pharmaceuticalintelligence.com/2015/09/26/outstanding-achievement-in-anesthesiology/

 

36o    Outstanding Achievements in Radiology or Radiotherapy

Curator: Larry H Bernstein, MD, FCAP

https://pharmaceuticalintelligence.com/2015/09/26/outstanding-achievements-in-radiology-or-radiotherapy/

 

35o    A Future for Plasma Metabolomics in Cardiovascular Disease Assessment

Curator: Larry H Bernstein, MD, FCAP

https://pharmaceuticalintelligence.com/2014/09/09/a-future-for-plasma-metabolomics-in-cardiovascular-disease-assessment/

 

34o    Titanium-nitric-oxide-coated bioactive stents in acute coronary syndrome

Reporter: Larry Bernstein, MD, FCAP

https://pharmaceuticalintelligence.com/2014/08/10/titanium-nitric-oxide-coated-bioactive-stents-in-acute-coronary-syndrome/

 

33o    Why did this occur? The matter of Individual Actions Undermining Trust, The Patent Dilemma and The Value of a Clinical Trials

Reporter and Curator: Larry H. Bernstein, MD, FCAP

https://pharmaceuticalintelligence.com/2014/07/18/why-did-this-occur/

 

32o    Life-work in Engineering of Improved Heart Valve

Curator and Reporter: Larry H Bernstein, MD, FCAP

https://pharmaceuticalintelligence.com/2014/07/15/life-work-in-engineering-of-improved-heart-valve/

 

31o    USPTO Guidance On Patentable Subject Matter

Curator and Reporter: Larry H Bernstein, MD, FCAP

https://pharmaceuticalintelligence.com/2014/07/03/uspto-guidance-on-patentable-subject-matter/

 

30o    Unstable Arterial Plaques

Curator & Author: Justin D Pearlman, MD, PhD, FACC

https://pharmaceuticalintelligence.com/2014/06/08/unstable-arterial-plaques/

 

29o    Summary – Volume 4, Part 2:  Translational Medicine in Cardiovascular Diseases

Author and Curator: Larry H Bernstein, MD, FCAP

https://pharmaceuticalintelligence.com/2014/05/10/summary-part-2-volume-4-translational-medicine-in-cardiovascular-diseases/

 

28o  The Role of Medical Imaging in Personalized Medicine

Author & Reporter: Dror Nir, PhD

https://pharmaceuticalintelligence.com/2014/01/13/the-roll-of-medical-imaging-in-personalized-medicine/

 

27o    Summary of Genomics and Medicine: Role in Cardiovascular Diseases

Author: Larry H. Bernstein, MD, FCAP

https://pharmaceuticalintelligence.com/2014/01/06/summary-of-genomics-and-medicine-role-in-cardiovascular-diseases/

 

26o    Diagnostic Value of Cardiac Biomarkers

Author and Curator: Larry H Bernstein, MD, FCAP 

https://pharmaceuticalintelligence.com/2014/01/04/diagnostic-value-of-cardiac-biomarkers/

 

25o    The Cost to Value Conundrum in Cardiovascular Healthcare Provision

Author: Larry H. Bernstein, MD, FCAP

https://pharmaceuticalintelligence.com/2014/01/01/the-cost-to-value-conundrum-in-cardiovascular-healthcare-provision/

 

24o    Hyperhomocysteinemia interaction with Protein C and Increased Thrombotic Risk

Reporter and Curator: Larry H Bernstein, MD, FCAP

https://pharmaceuticalintelligence.com/2013/12/03/hyperhomocysteinemia-interaction-with-protein-c-and-increased-thrombotic-risk/

23o    Triggering of Plaque Disruption and Arterial Thrombosis

Curator and Reporter: Larry H Bernstein, MD, FCAP

https://pharmaceuticalintelligence.com/2013/10/13/triggering-of-plaque-disruption-and-arterial-thrombosis/

 

22o    The Effects of Bovine Thrombin on HUVEC and AoSMC

Curators: Demet Sağ,^1,*and Jeffrey Harold Lawson^1,2

https://pharmaceuticalintelligence.com/2013/07/20/the-effects-of-bovine-thrombin-on-huvec-and-aosmc/

 

21o    Topical Bovine Thrombin Induces Vascular Cell Proliferation

Demet Sağ, Kamran Baig*, Steven Hanish*, Jeffrey Lawson

https://pharmaceuticalintelligence.com/2013/07/20/topical-bovine-thrombin-induces-vascular-cell-proliferation/

20o    The Effects of Aprotinin on Endothelial Cell Coagulant Biology

Authors: Demet Sag, PhD*†, Kamran Baig, MBBS, MRCS; James Jaggers, MD, Jeffrey H. Lawson, MD, PhD

https://pharmaceuticalintelligence.com/2013/07/20/the-effects-of-aprotinin-on-endothelial-cell-coagulant-biology/

 

19o    AHA, ACC Change in Requirement for Surgical Support: Class IIb -> Class III, Level of Evidence A: Supports Non-emergent PCI without Surgical Backup (Change of class IIb, Level of Evidence B).

Author, Curator, and Co-Editor of Series A, Volumes 1,2,3,4,5, Author and Curator Volume 6: Larry H Bernstein, MD, FCAP

and

Author and Co-Editor, Series A, Volumes Two & Six, and Content Consultant to Six-Volume e-SERIES A: Cardiovascular Diseases: Justin Pearlman, MD, PhD, FACC

https://pharmaceuticalintelligence.com/2013/07/17/aha-acc-change-in-requirement-for-surgical-support-class-iib-class-iia-level-of-evidence-a-support-nonemergent-pci-without-surgical-backup-change-of-class-iib-level-of-evidence-b/

 

18o    Treatment Options for Left Ventricular Failure – Temporary Circulatory Support: Intra-aortic balloon pump (IABP) – Impella Recover LD/LP 5.0 and 2.5, Pump Catheters (Non-surgical) vs Bridge Therapy: Percutaneous Left Ventricular Assist Devices (pLVADs) and LVADs (Surgical)

Author: Larry H Bernstein, MD, FCAP And Curator: Justin D Pearlman, MD, PhD, FACC

https://pharmaceuticalintelligence.com/2013/07/17/treatment-options-for-left-ventricular-failure-temporary-circulatory-support-intra-aortic-balloon-pump-iabp-impella-recover-ldlp-5-0-and-2-5-pump-catheters-non-surgical-vs-bridge-therapy/

 

17o    DELETED is identical to 41co

 

16o    DELETED identical to 39co

 

15o    DELETED identical to 38co

 

14o    The Implications of a Newly Discovered  CYP2J2 Gene Polymorphism Associated with Coronary Vascular Disease in the Uygur Chinese Population

Author, Curator: Larry H Bernstein, MD, FCAP

https://pharmaceuticalintelligence.com/2013/05/24/the-implications-of-a-newly-discovered-cyp2j2-gene-polymorphism-associated-with-coronary-vascular-disease-in-the-uygur-chinese-population/

 

13o    DELETED identical to 4co

12o    DELETED – identical to 35co

11o    DELETED identical to 34co

10o    Treatment for Infective Endocarditis

Curator: Larry H Bernstein, MD, FACP

https://pharmaceuticalintelligence.com/2013/03/30/treatment-for-infective-endocarditis/

9o     Accurate Identification and Treatment of Emergent Cardiac Events

Curator: Larry H Bernstein, MD, FCAP

https://pharmaceuticalintelligence.com/2013/03/15/accurate-identification-and-treatment-of-emergent-cardiac-events/

8o     Nanotechnology and Heart Disease

Author and Curator:  Tilda Barliya PhD

https://pharmaceuticalintelligence.com/2013/03/04/nanotechnology-and-heart-disease/

 

7o     Cardiovascular Imaging

Author: Justin D. Pearlman, MD, PhD, FACC

https://pharmaceuticalintelligence.com/2013/02/04/cardiovascular-imaging/

6o     Introducing Dr. Tim Wu – Interventional Cardiologist, Inventor and Entrepreneur

Author: Ed Kislauskis, PhD

https://pharmaceuticalintelligence.com/2013/01/14/introducing-dr-tim-wu-interventional-cardiologist-inventor-and-entrepreneur/

 

5o     Reduction in Inappropriate Therapy and Mortality through ICD Programming

Reporter: Dr Aviral Vatsa, PhD, MBBS

https://pharmaceuticalintelligence.com/2013/01/04/reduction-in-inappropriate-therapy-and-mortality-through-icd-programming/

4o     Assessing Cardiovascular Disease with Biomarker

Author and Curator: Larry H Bernstein, MD, FCAP

https://pharmaceuticalintelligence.com/2012/12/25/assessing-cardiovascular-disease-with-biomarkers/

 

3o     Nitric Oxide and it’s impact on Cardiothoracic Surgery

Author, curator: Tilda Barliya PhD

https://pharmaceuticalintelligence.com/2012/12/15/nitric-oxide-and-its-impact-on-cardiothoracic-surgery/

 

2o     Biochemistry of the Coagulation Cascade and Platelet Aggregation: Nitric Oxide: Platelets, Circulatory Disorders, and Coagulation Effects

Curator/Editor/Author: Larry H. Bernstein, MD, FCAP 

https://pharmaceuticalintelligence.com/2012/11/26/biochemistry-of-the-coagulation-cascade-and-platelet-aggregation/

1o     Interaction of Nitric Oxide and Prostacyclin in Vascular Endothelium

Author: Larry H. Bernstein, MD

https://pharmaceuticalintelligence.com/2012/09/14/interaction-of-nitric-oxide-and-prostacyclin-in-vascular-endothelium/